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Optic neuritis (ON) was rarely reported in juvenile idiopathic arthritis (JIA) patients, particu-
larly in those under anti-tumor necrosis factor alpha blockage. However, to our knowledge,
the prevalence of ON in JIA population has not been studied. Therefore, 5793 patients were
followed up at our University Hospital and 630 (11%) had JIA. One patient (0.15%) had ON
and was reported herein. A 6-year-old male was diagnosed with extended oligoarticular JIA,
and received naproxen and methotrexate subsequently replaced by leﬂunomide. At 11 years
old, he was diagnosed with aseptic meningitis, followed by a partial motor seizure with sec-
ondary generalization. Brain magnetic resonance imaging (MRI) and electroencephalogram
showed diffuse disorganization of the brain electric activity and leﬂunomide was suspended.
Seven days later, the patient presented acute ocular pain, loss of acuity for color, blurred
vision, photophobia, redness and short progressive visual loss in the right eye. A fundoscopic
exam detected unilateral papilledema without retinal exudates. Orbital MRI suggested right
ON. The anti-aquaporin 4 (anti-AQP4) antibody was negative. Pulse therapy with methyl-
prednisolone was administered for ﬁve days, and subsequently with prednisone, he had
clinical and laboratory improvement. In conclusion, a low prevalence of ON was observed
in  our JIA population. The absence of anti-AQP4 antibody and the normal brain MRI do not
exclude the possibility of demyelinating disease associated with chronic arthritis. Therefore,rigorous follow up is required.
© 2014 Elsevier Editora Ltda. All rights reserved.
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Neurite  óptica  em  paciente  com  artrite  idiopática  juvenil
Palavras-chave:
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Anticorpo antiaquaporina 4
r  e  s  u  m  o
A neurite óptica (NO) raramente é relatada em pacientes com artrite idiopática juvenil
(AIJ), especialmente naqueles que utilizam tratamento com bloqueador de fator de necrose
tumoral-alfa. No entanto, até onde se sabe, a prevalência de NO em pacientes com AIJ
ainda  não foi estudada. Acompanharam-se 5.793 pacientes no Hospital Universitário desta
instituic¸ão.  Destes, 630 (11%) tinham AIJ, e apenas um (0,15%) apresentava NO.  O paciente
com NO, de 6 anos de idade e do sexo masculino, foi diagnosticado com AIJ oligoarticular
estendida. Foram introduzidos naproxeno e metotrexato, posteriormente substituídos por
leﬂunomida. Aos 11 anos de idade, ele foi diagnosticado com meningite asséptica, seguida
de  convulsão motora parcial com evoluc¸ão para generalizac¸ão secundária. A ressonância
magnética do encéfalo e o eletroencefalograma evidenciaram desorganizac¸ão difusa da
atividade elétrica do encéfalo. A leﬂuomida foi suspensa. Após 7 dias, o paciente apresen-
tou  dor ocular aguda, baixa acuidade visual para cores, visão turva, fotofobia, hiperemia e
amaurose progressiva no olho direito. No exame de fundo de olho, foi detectado edema de
papila  unilateral sem exsudatos retinianos. A ressonância magnética de órbita sugeriu neu-
ropatia óptica à direita. O anticorpo antiaquaporina 4 (anti-AQP4) foi negativo. O paciente
foi  submetido a pulsoterapia com metilprednisolona por cinco dias, seguida de prednisona,
apresentando melhora clínica e laboratorial. Em suma, foi observada baixa prevalência de
NO em pacientes com AIJ. A ausência do anticorpo antiaquaporina 4 e a ressonância mag-
nética normal do encéfalo não excluem a possibilidade de doenc¸a desmielinizante associada
a  esta artrite crônica. Logo, é importante que seja feito um acompanhamento rigoroso.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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ptic neuritis (ON) is characterized by acute visual loss and
ptic nerve inﬂammation. The most common clinical mani-
estations of this disease are sudden vision loss, disturbance
f color vision and periorbital, and retro-orbital pain mainly
uring eye movement.1 This visual abnormality may be asso-
iated with infections, vaccinations, drugs and autoimmune
iseases, particularly multiple sclerosis (MS) and neuromieli-
is optic (NMO).2,3
Of note, ON was rarely reported in juvenile idiopathic
rthritis (JIA) patients, particularly in those under tumor
ecrosis factor alpha (TNF-)  blockage.3–6 However, to our
nowledge, the prevalence of ON in JIA population has not
een studied.
Therefore, from January 1983 to July 2013, 5793 patients
ere followed up at the Pediatric Rheumatology Unit of the
hildren’s Institute, Faculdade de Medicina da Universidade
e São Paulo. Out of those, 630 (11%) fulﬁlled the International
eague of Associations for Rheumatism (ILAR) classiﬁcation
riteria for JIA.7 Only one (0.15%) had acute visual loss due to
N during the disease course and was reported herein.
ase  report
 6-year-old male was diagnosed with extended oligoar-
icular JIA based on chronic arthritis of left knee with
rogression to the wrists and ankles. The initial labora-
ory exams revealed hemoglobin 12.9 g/dL, hematocrit 38.1%,
hite blood cell count 17,700 mm3 (73% neutrophils, 23%lymphocytes, 0% eosinophils and 4% monocytes), platelet
count 401,000 mm3, erythrocyte sedimentation rate (ESR)
30 mm/1st, C-reactive protein (CRP) 98.4 mg/dL (normal range
5.0), rheumatoid factor and antinuclear antibody (ANA)
were negative. Naproxen (20 mg/kg/day) and methotrexate
(0.5 mg/kg/week) were introduced and subsequently changed
for leﬂunomide (20 mg/day) due to gastric intolerance. At
11 years old, no arthritis or limitations were present and
he had been treated with leﬂunomide (20 mg/day). At that
moment, he presented headache and vomits without fever,
followed after four days by a partial motor seizure affecting
the right arm with secondary generalization. The laboratory
ﬁndings showed cerebral spinal ﬂuid (CSF): slightly muddy,
127 cells/mm2 (32% lymphocytes, 19% monocytes, 1% plas-
mocytes, 43% neutrophils, 2% eosinophils, 1% basophils and
2% macrophages), red blood cells 0/mm2, protein 61 mg/dL,
glucose 58 mg/dL and adenosine deaminase 0.7 IU/l (normal
range <4). ESR was 30 mm/1st hour and CRP was 10.1 mg/dL.
The DNA detections by polymerase chain reaction in CSF
for adenovirus, cytomegalovirus, herpes simplex type I/II,
Toxoplasma gondii,  Mycobacterium tuberculosis and Treponema
pallidum were negative, as well as aerobic, anaerobic, fun-
gus and mycobacteria CSF cultures. Brain magnetic resonance
imaging (MRI) was normal and electroencephalogram showed
diffuse disorganization of the brain electric activity. Therefore,
aseptic meningoencephalitis was diagnosed and leﬂunomide
was suspended. Seven days later, the patient presented acute
ocular pain, low visual acuity for colors, blurred vision, photo-
phobia and redness in the right eye, progressing to unilateral
visual loss. Fundoscopic exam detected right papilledema
and dry macula, without macular exudates. Orbital MRI
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showed thickening and hyperintensity on T2 associated with
enhancement of the intraorbital, intracanalicular and cister-
nal segments of the right optic nerve, strongly suggested right
ON. Immunological tests showed antinuclear antibodies ANA
1:160 (ﬁne speckled pattern), negative anti-double-stranded
DNA, anti-Sm, anti-RNP, IgG and IgM anticardiolipin, anti-Ro
and anti-La negatives. The serum anti-aquaporin 4 (anti-
AQP4) antibody by indirect immunoﬂuorescence was negative.
Pulse therapy with methylprednisolone (1.0 g/day) was admin-
istered for ﬁve consecutive days and subsequently prednisone
(60 mg/day). After a 30-day treatment with prednisone, clin-
ical, laboratory and fundoscopic, the exams were normal.
Currently, he is on corticosteroid tapering.
Discussion
ON with reversible visual loss in JIA population was infre-
quently described in our pediatric rheumatology service for
30 consecutive years.
Of note, this ophthalmic disease occurs most commonly
in young patients8 and without gender predominance.9–11
The diagnosis is based on clinical features secondary to
optic nerve damage,9–11 resulting in sudden vision loss, color
vision impairment and periorbital pain in eye movement.
Papilledema may be observed in the fundoscopic exam in one
third of patients,1 as a result of papillitis, perineuritis or neu-
roretinitis. In our patient, the presence of swollen disk without
macular star exudates suggests a papillitis associated with
a retrobulbar neuritis. Interestingly, retrobulbar neuritis and
papillitis are mainly related with MS, whereas perineuritis
and neuroretinitis are more  often associated with infectious
or inﬂammatory etiologies.
The orbital MRI  is not required to conﬁrm the diagno-
sis. However, it is necessary to exclude other disorders, that
can mimic  ON, such as compressive or inﬂammatory orbital
lesions.12,13 Importantly, nearly 50% of the patients with iso-
lated ON develop MS  over a period of 15 years. Consequently,
brain MRI  should be performed to ﬁnd early symptoms for
demyelinating brain lesions and closely monitor the disease
evolution.12,14
In addition, our patient had negative anti-AQP4 anti-
body. This autoimmune marker targeting the central nervous
system has high speciﬁcity for the spectrum of NMO
diagnosis.15 However, 53% of sensitivity was detected by
indirect immunoﬂuorescence method.16 Ten percent of
seronegative patients that present recurrent ON will develop
NMO within ﬁve years.14 Therefore, the rigorous follow-up of
our patient is of the utmost importance.
In JIA population, ON was rarely reported, usually asso-
ciated with TNF- inhibitors,4 with a median of 8 months
treatment.3,6 Furthermore, this ocular abnormality was also
described in adult patients with inﬂammatory arthritis.17 The
etiology for ON in our patient is unclear and possibly related
to autoimmunity. To our knowledge, no ON case was reported
under leﬂunomide therapy.
Intravenous methylprednisolone is an option of ON treat-
19ment, as indicated herein. A recent review, including
randomized trials in adult populations, evidenced similar
recovery of normal visual acuity in patients treated with intra-
venous or oral corticosteroids.18
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In conclusion, a low prevalence of ON was observed in our
JIA population. The absence of anti-AQP4 antibody and the
normal brain MRI  do not exclude the possibility of demyelinat-
ing disease associated with this chronic arthritis. Therefore,
rigorous follow up is required.
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